ChemAbout

ChemAbout is a B2B platform where chemical buyers and suppliers discover each other.

Post a purchase requestList your products (for suppliers)
© 2026 ChemAbout
Compound Index|Demand Board|Insights|Exhibitions|Compliance|Help Center|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/API/Setmelanotide acetate
C55H80N18O15S2
1297.5 g/mol
API

Setmelanotide acetate

CAS1504602-49-6
Category
API
Compound Class
Peptide
Primary Use
Pharmaceutical Raw Material

Setmelanotide acetate is a pharmaceutical active ingredient consisting of a cyclic peptide salt form. It is a melanocortin 4 receptor agonist used as a research compound in metabolic disorder studies.

pharmaceutical raw materialresearch compound for metabolic disorder studies

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing Setmelanotide acetate?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→

Related Compounds

StrongSame Parent

Setmelanotide

CAS920014-72-8

pharmaceutical raw material

SimilarStructure SimilarSimilarity 0.72

MT-II

CAS121062-08-6

pharmaceutical raw material

ApplicationSame Use

Inecalcitol

CAS163217-09-2

pharmaceutical raw material

ApplicationSame Use

Norglipin

CAS16444-19-2

pharmaceutical raw material

ApplicationSame Use

Dexamethasone 7,9-diene

CAS1809224-82-5

pharmaceutical raw material

ApplicationSame Use

Mesna

CAS19767-45-4

pharmaceutical raw material

ReferenceSame Category

Methyl(nitroso){3-phenyl-3-[4-(trifluoromethyl)phenoxy]propyl}amine

CAS150494-06-7

pharmaceutical raw material

ReferenceSame Category

Daridorexant

CAS1505484-82-1

pharmaceutical raw material

Related Reading

Therapeutic Peptides in 2026: This Year's Breakthroughs

2026 has been a concentrated year for peptide therapeutics. Efficacy reached a new high in late-stage trials, the obesity field moved beyond the incretins to amylin, the oral route reached weight management, and peptide-guided radioligand therapy kept advancing — each point tied to a specific 2025–2026 result.

Read more
Identifiers
IUPAC Name

(4R,7S,10S,13R,16S,19R,22R)-22-[[(2S)-2-acetamido-5-(diaminomethylideneamino)pentanoyl]amino]-13-benzyl-10-[3-(diaminomethylideneamino)propyl]-16-(1H-imidazol-5-ylmethyl)-7-(1H-indol-3-ylmethyl)-19-methyl-6,9,12,15,18,21-hexaoxo-1,2-dithia-5,8,11,14,17,20-hexazacyclotricosane-4-carboxamide;acetic acid

InChIKey

PILXXDANZBQUJH-AKVBKPKISA-N

SMILES

C[C@@H]1C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)C)C(=O)N)CC2=CNC3=CC=CC=C32)CCCN=C(N)N)CC4=CC=CC=C4)CC5=CN=CN5.CC(=O)O.CC(=O)O.CC(=O)O

Synonyms (3)
  • Imcivree
  • RM-493 acetate
  • Setmelanotide acetate

Sourcing Setmelanotide acetate?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→